Welcome to our dedicated page for Angi SEC filings (Ticker: ANGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Angi Inc. filings document the formal disclosures of a Nasdaq-listed digital home services marketplace. Recent Form 8-K reports furnish quarterly results and Regulation FD materials, record executive appointments and resignations, and describe restructuring charges, operating-expense actions and material financing arrangements.
The company’s proxy materials cover board elections, equity incentive plan matters, auditor ratification and annual-meeting procedures. Other filings detail credit-agreement terms for Angi’s operating subsidiary, including revolving credit facility structure, guarantees, collateral, borrowing mechanics and covenant-related disclosures. Together, the filing categories describe Angi’s governance, capital structure, public reporting, marketplace operations and risk-related corporate events.
The Vanguard Group filed Amendment No. 7 to its Schedule 13G disclosing its beneficial ownership of Angi Inc. (NASDAQ: ANGI) common stock as of 30 June 2025.
The filing shows Vanguard beneficially owns 4,899,419 shares, representing 10.21 % of Angi’s outstanding common shares. Vanguard reports 0 shares with sole voting power and 27,425 shares with shared voting power. Dispositive authority is larger, with 4,823,182 shares under sole dispositive power and 76,237 shares under shared dispositive power.
Vanguard is classified as an investment adviser (Type IA) and certifies that the stake is held in the ordinary course of business, not to influence control. Because the holding exceeds the 10 % threshold, Vanguard must report under Section 13(d) of the Exchange Act, but the passive Schedule 13G filing signals no activist intent.
The disclosure confirms a large, diversified institution continues to maintain a significant passive position in Angi, potentially supporting market liquidity and investor confidence while exerting limited direct governance influence due to the absence of sole voting power.
Angi director Suzy Welch reported the vesting of restricted stock units (RSUs) on June 20, 2025. The transaction involved the conversion of 2,580 RSUs into Class A Common Stock on a one-for-one basis, increasing her direct holdings to 19,003 shares.
Key details of the RSU grant:
- Original grant date: June 20, 2023
- Vesting schedule: Equal installments over three years
- Vesting condition: Continued service as director
- Conversion rate: One-for-one into Class A Common Stock
The Form 4 was filed by Shannon M. Shaw as Attorney-in-Fact for Welch on June 23, 2025. This transaction represents a routine vesting event of director compensation and does not involve any open market transactions.
Angi director Jeremy Philips reported the vesting of restricted stock units (RSUs) on June 20, 2025. The transaction involved the conversion of 2,580 RSUs into Class A Common Stock on a one-for-one basis.
Key transaction details:
- Acquired 2,580 shares of Class A Common Stock through RSU conversion
- Post-transaction direct ownership increased to 12,207 shares
- RSUs were granted on June 20, 2023, with a three-year vesting schedule in equal annual installments
- Transaction was executed under transaction code 'M' (exercise or conversion of derivative security)
The Form 4 was filed by Shannon M. Shaw as Attorney-in-Fact for Jeremy Philips on June 23, 2025, within the required reporting timeline. This transaction represents a scheduled vesting event rather than an open market transaction.
Form 4 snapshot: On 06/17/2025 Angi Inc. (ANGI) director Sandra M. Buchanan reported an award of 16,436 restricted stock units (RSUs). The transaction code “A” confirms it was a grant, not a market purchase or sale, and was executed at $0 cost under the company’s equity compensation plan. Each RSU converts into one share of Class A common stock.
The RSUs vest in three equal annual installments on each anniversary of the 06/17/2025 grant date, contingent on continued board service. Under Buchanan’s deferral election, any vested shares will be delivered in a lump-sum after her service ends. After this grant, she beneficially owns 16,436 derivative securities, held directly. No dispositions or additional transactions were disclosed.
No ordinary shares were bought or sold, and the filing does not reference a Rule 10b5-1 trading plan. The event is a routine director compensation grant with minimal direct market impact.
Form 4 snapshot – Angi Inc. (ANGI), filed 06/20/2025: Director Alesia J. Haas reported the grant of 16,436 Restricted Stock Units (RSUs) on 06/17/2025. Each RSU converts into one share of Class A common stock upon settlement.
Key transaction details:
- Transaction code: A (award/grant, no open-market purchase or sale).
- Price: $0 – equity granted as compensation.
- Vesting schedule: Equal annual installments over three years on the anniversary of the 06/17/2025 grant date, contingent on continued service.
- Deferral election: Any vested RSUs will be settled in a lump sum after termination of service.
- Post-transaction beneficial ownership: 16,436 Class A shares held directly through RSUs.
No sales, option exercises, or other derivative activities were reported. The filing therefore reflects routine director compensation rather than a market-driven trade. While the grant modestly increases insider equity alignment, it does not signal a change in corporate outlook or provide new information on Angi’s operational or financial performance.
Form 4 Overview – Angi Inc. (ANGI)
Director Glenn H. Schiffman filed a Form 4 disclosing one equity grant executed on 17 June 2025. The filing shows no open-market purchases or sales; rather, the report reflects the issuance of 16,436 Restricted Stock Units (RSUs), each convertible into one share of Class A common stock.
Key details of the grant
- Type of security: RSUs tied to Class A common stock, par value $0.001.
- Grant size: 16,436 units.
- Vesting schedule: Equal annual installments over three years on each anniversary of the 17 June 2025 grant date, subject to continued service. Per the director’s deferral election, settlement occurs in a lump sum after service termination.
- Exercise price: Not applicable (RSUs granted at $0 cost).
Post-transaction ownership
- Directly held Class A shares: 34,014.
- Directly held RSUs: 16,436.
Contextual notes
- Amounts reflect Angi’s 1-for-10 reverse stock split effective 24 March 2025.
- The filing references the 31 March 2025 spin-off distribution from IAC Inc., by which the reporting person previously received 32,156 post-split shares; that prior distribution is exempt under Rule 16a-9(a) and does not involve today’s transaction.
This Form 4 signals additional equity alignment for the director but does not involve cash transactions or disposals that would directly affect Angi’s public float.
Angi Inc. (ANGI) – Form 4 insider filing dated 06/20/2025
Director Suzy Welch reported the grant of 16,436 Restricted Stock Units (RSUs) on 06/17/2025. Each RSU entitles the holder to receive one share of Angi Class A common stock when vested. The RSUs vest in three equal annual instalments on each anniversary of the 17 Jun 2025 grant date, conditional on continued board service. Per Ms. Welch’s deferral election, any vested shares will be delivered in a lump-sum after her service ends.
The award was reported at a $0 acquisition price, reflecting a standard equity-based compensation grant to non-employee directors. Following the transaction, Ms. Welch’s beneficial ownership stands at 16,436 derivative securities; no open-market purchases or sales were disclosed.
The filing indicates routine director compensation and does not involve cash consideration, option exercises, or disposition of shares. There are no amendments, sales, or 10b5-1 trading plan notations in this submission.
Angi Inc. (ANGI) – Form 4 Insider Transaction Summary
Director Thomas C. Pickett reported the grant of 16,436 restricted stock units (RSUs) on 17 June 2025. Each RSU represents the right to receive one share of Angi’s Class A common stock at no cost when vested. The award vests in three equal annual instalments on each anniversary of the grant date, contingent on Mr. Pickett’s continued service. Any vested units will be settled in a lump-sum distribution after termination of service pursuant to the director’s deferral election. Following this grant, Mr. Pickett beneficially owns 16,436 derivative securities, held directly. No open-market purchase or sale occurred, and no cash consideration was exchanged.
No other equity transactions or changes in ownership were disclosed in the filing.
Angi Inc. (ANGI) filed a Form 4 on 20-Jun-2025 detailing an equity award made to director Jeremy G. Philips.
On 17-Jun-2025, Philips received 16,436 Restricted Stock Units (RSUs) coded “A” (grant) at a price of $0.00. Each RSU represents the contingent right to receive one share of Class A Common Stock.
The award vests in three equal annual installments on each anniversary of the 17-Jun-2025 grant date, subject to continued board service. Under the director’s deferral election, any shares that vest will be delivered in a lump-sum distribution after his service terminates.
Following the grant, Philips beneficially owns 16,436 derivative securities, held directly. No open-market purchases, sales, or option exercises were reported, and the filing does not disclose any other changes to beneficial ownership.
Because the transaction is a routine board equity grant with no immediate cash outflow or share sale, the filing has limited direct financial impact; however, it reinforces equity-based alignment between the director and shareholders.